Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canada’s CGPA Installs New Leaders

Appoints New Chair And Vice-Chair From Pharmascience And Apotex

Executive Summary

Canada’s off-patent industry association has looked to Pharmascience and Apotex for its new chair and vice-chair.

You may also be interested in...



Canada Must Learn ‘Difficult Lessons’ From COVID-19

Canadian policymakers must learn “difficult lessons” from the coronavirus pandemic and support measures to bolster domestic production and secure the country’s position as part of the global supply chain, according to CGPA president Jim Keon.

Aspen Expects Growth Following Sandoz And Viatris Deals

Aspen expects to report significant growth in its continuing operations for the first half of its financial year, following deals with Sandoz and Viatris that have seen the South African firm divest major businesses in Japan and Europe.

Three Pillars Must Support Value Added Medicines In EU

Medicines for Europe has called for fresh efforts to bolster the value added medicines sector and “level the playing field” with the US and its 505(b)(2) pathway, launching a new report setting out the three key areas in which greater EU action is needed.

Topics

UsernamePublicRestriction

Register

LL1131980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel